Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus ...

Elevance Health's dependence on government plans is considerable, but even with very conservative growth expectations, ELV ...

Elevance Health is the latest health insurance company to report higher-than-expected medical costs as third quarter profits ...

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Elevance Health (ELV – Research Report), with a ...

Elevance Health faces profitability issues, impacting its stock price. See more about ELV stock's cautious hold rating and ...

Bernstein lowered the firm’s price target on Elevance Health (ELV) to $549 from $665 and keeps an Outperform rating on the shares. The ...

Elevance Health cut its annual profit expectation on Thursday due to increased medical costs in its government-backed plans, ...

Elevance Health Inc. is seeking to sell investment-grade bonds as the big US insurer’s shares have fallen the most since 2020 ...

Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its ...

Elevance Health (NYSE:ELV – Get Free Report) had its price objective dropped by stock analysts at TD Cowen from $589.00 to $484.00 in a report released on Monday, Benzinga reports. The brokerage ...

Q3 2024 Earnings Call Transcript October 17, 2024 Elevance Health Inc. misses on earnings expectations. Reported EPS is $8.37 ...

Elevance Health shares plunged Thursday after the insurer reported lower-than-expected earnings and cut its outlook as ...